Amgen Has US Rituximab Nod - But No RA Indication

Riabni Biosimilar Rival To Rituxan Seeks To Compete With Price Discount

 
• By David Wallace
  
Cut Price Dollar Scissors
Amgen’s price discount matches that of Pfizer • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin